Back to Search
JUDY POE, PHARMD
PHARMD
Pharmacist
NPI: 1255932513Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
26027344A(IN)
Research & Publications (20)
CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms.
PMID 15378059·Nat Immunol·2004
7-preclinical
CD19, CD21, and CD22: multifaceted response regulators of B lymphocyte signal transduction.
PMID 11913948·Int Rev Immunol·2001
6-review
CD22 forms a quaternary complex with SHIP, Grb2, and Shc. A pathway for regulation of B lymphocyte antigen receptor-induced calcium flux.
PMID 10748054·J Biol Chem·2000
7-preclinical
Mechanical cavopulmonary assist maintains pulmonary and cerebral blood flow in a piglet model of a bidirectional cavopulmonary shunt with high pulmonary vascular resistance.
PMID 19185151·J Thorac Cardiovasc Surg·2009
7-preclinical
Effect of chitosan glutamate, carbomer 974P, and EDTA on the in vitro Caco-2 permeability and oral pharmacokinetic profile of acyclovir in rats.
PMID 19294548·Drug Dev Ind Pharm·2009
7-preclinical
Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcgammaRI, FcgammaRIII, and FcgammaRIV.
PMID 18495955·Blood·2008
7-preclinical
The use of 1-aminobenzotriazole in differentiating the role of CYP-mediated first pass metabolism and absorption in limiting drug oral bioavailability: a case study.
PMID 19356080·Drug Metab Lett·2008
7-preclinical
A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses.
PMID 18482568·Immunity·2008
7-preclinical
CD22 regulates time course of both B cell division and antibody response.
PMID 18178830·J Immunol·2008
7-preclinical
Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice.
PMID 18093919·Proc Natl Acad Sci U S A·2007
7-preclinical
CD22 ligand binding regulates normal and malignant B lymphocyte survival in vivo.
PMID 16920943·J Immunol·2006
7-preclinical
Porcine brain microvessel endothelial cells as an in vitro model to predict in vivo blood-brain barrier permeability.
PMID 16896068·Drug Metab Dispos·2006
7-preclinical
B cell antigen receptor and CD40 differentially regulate CD22 tyrosine phosphorylation.
PMID 16393971·J Immunol·2006
7-preclinical
The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice.
PMID 15778404·J Immunol·2005
7-preclinical
Complement component C3d-antigen complexes can either augment or inhibit B lymphocyte activation and humoral immunity in mice depending on the degree of CD21/CD19 complex engagement.
PMID 16339538·J Immunol·2005
7-preclinical
CD22: a multifunctional receptor that regulates B lymphocyte survival and signal transduction.
PMID 16227086·Adv Immunol·2005
6-review
Immunotherapy using unconjugated CD19 monoclonal antibodies in animal models for B lymphocyte malignancies and autoimmune disease.
PMID 16217038·Proc Natl Acad Sci U S A·2005
7-preclinical
B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae.
PMID 16039575·Immunity·2005
7-preclinical
The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system.
PMID 15564717·Curr Dir Autoimmun·2005
6-review
The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy.
PMID 15210744·J Exp Med·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3701 PORTAGE AVE
SOUTH BEND, IN 46628 - Phone
- (574) 243-5849
Quick Facts
- NPI
- 1255932513
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile